Figure 5. Combined treatment of QUE and TMZ increases overall survival rate of mice with orthotopic GSC-initiated glioblastomas.
(A) Representative bioluminescence images of mice bearing orthotopically implanted luciferase-labeled GL-261 glioma cells after treatment of QUE, TMZ or combined QUE+TMZ, for 14 or 21 days, respectively. (B) The Kaplan–Meier plot showing survival rate of mice in different treatment groups (n = 10 per group).